TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
NERV

Minerva Neurosciences Inc

Healthcare · Biotechnology

3.40$ +0.0% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow NERV
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – -105.5% -82.1% – – – – –
– – – – – 0.4% 0.4% – – – – –
– – – – – 22.3% 23.6% – – – – –
– – – – – 62.9% 23.6% – – – – –
– – – – – 8.3% -110.6% – – – – –
– – – – – 0.0% 0.0% – – – – –
– – – – – 34.2% 59.6% – – – – –
– – – – – 1.3% 32.1% – – – – –
– – – – – 1.3% 32.1% – – – – –
– – – – – -70.0% 9.6% – – – – –
– – – – – -105.5% -82.1% – – – – –

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?